A PHASE-TWO, RANDOMISED, PLACEBO-CONTROLLED TRIAL OF BELIMUMAB IN RENAL TRANSPLANTATION SUGGESTS DE NOVO ANTIBODY FORMATION IS REDUCED IN BELIMUMAB TREATED PATIENTS
TRANSPLANT INTERNATIONAL(2017)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
TRANSPLANT INTERNATIONAL(2017)